Sensorcaine Injection, Solution
NDC Package 63323-472-33
Package Information
Sensorcaine (bupivacaine hydrochloride) injection is sensorcaine (bupivacaine HCl) is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see WARNINGS). This formulation utilizes a injection, solution delivery system. Marketed by Fresenius Kabi Usa, Llc, this product is identified by NDC 63323-472 and is authorized under FDA application ANDA070554.
Identification & Billing
- RxCUI: 1012377 - BUPivacaine HCl 0.25 % / EPINEPHrine 1:200,000 Injectable Solution
- RxCUI: 1012377 - bupivacaine hydrochloride 2.5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution
- RxCUI: 1012377 - bupivacaine hydrochloride 0.25 % / epinephrine (as epinephrine bitartrate) 1:200,000 Injectable Solution
- RxCUI: 1012384 - BUPivacaine HCl 0.5 % / EPINEPHrine 1:200,000 Injectable Solution
- RxCUI: 1012384 - bupivacaine hydrochloride 5 MG/ML / epinephrine 0.005 MG/ML Injectable Solution
Clinical Specifications
- Epidural - Administration upon or over the dura mater.
- Retrobulbar - Administration behind the pons or behind the eyeball.
Regulatory & Marketing
Hierarchy Structure
- 63323 - Fresenius Kabi Usa, Llc
- 63323-472 - Sensorcaine
- 63323-472-33 - 5 AMPULE in 1 BOX / 30 mL in 1 AMPULE
- 63323-472 - Sensorcaine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63323-472). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63323-472-33 identifies a specific commercial package of 5 ampule in 1 box / 30 ml in 1 ampule of Sensorcaine Mpf, a human prescription drug labeled by Fresenius Kabi Usa, Llc. This injection, solution is formulated for epidural; retrobulbar use and contains bupivacaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fresenius Kabi Usa, Llc on November 19, 2010. The current certification is valid through December 31, 2026.
How is this Fresenius Kabi Usa, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63323047233. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.